Schwickert A., Weghake E., Brüggemann K., Engbers A., Brinkmann B., Kemper B., Seggewiß J., Stock C., Ebnet K., Kiesel L., Riethmüller C., Götte M.
Forschungsartikel (Zeitschrift) | Peer reviewedMicroRNAs (miRNAs, micro ribonucleic acids) are pivotal post-transcriptional regulators of gene expression. These endogenous small non-coding RNAs play significant roles in tumorigenesis and tumor progression. miR-142-3p expression is dysregulated in several breast cancer subtypes. We aimed at investigating the role of miR-142-3p in breast cancer cell invasiveness. Supported by transcriptomic Affymetrix array analysis and confirmatory investigations at the mRNA and protein level, we demonstrate that overexpression of miR- 142-3p in MDA-MB-231, MDA-MB-468 and MCF-7 breast cancer cells leads to downregulation of WASL (Wiskott-Aldrich syndrome-like, protein: N-WASP), Integrin-αV, RAC1, and CFL2, molecules implicated in cytoskeletal regulation and cell motility. ROCK2, IL6ST, KLF4, PGRMC2 and ADCY9 were identified as additional targets in a subset of cell lines. Decreased Matrigel invasiveness was associated with the miR-142-3p-induced expression changes. Confocal immunofluorescence microscopy, nanoscale atomic force microscopy and digital holographic microscopy revealed a change in cell morphology as well as a reduced cell volume and size. A more cortical actin distribution and a loss of membrane protrusions were observed in cells overexpressing miR-142-3p. Luciferase activation assays confirmed direct miR-142-3p-dependent regulation of the 3'-untranslated region of ITGAV and WASL. siRNA-mediated depletion of ITGAV and WASL resulted in a significant reduction of cellular invasiveness, highlighting the contribution of these factors to the miRNAdependent invasion phenotype. While knockdown of WASL significantly reduced the number of membrane protrusions compared to controls, knockdown of ITGAV resulted in a decreased cell volume, indicating differential contributions of these factors to the miR-142-3p-induced phenotype. Our data identify WASL, ITGAV and several additional cytoskeleton- associated molecules as novel invasion-promoting targets of miR-142-3p in breast cancer.
| Brinkmann, Benjamin Franz | Fachbereich 05 Medizinische Fakultät (FB05) |
| Ebnet, Klaus | Institut für Medizinische Biochemie |
| Götte, Martin | Klinik für Frauenheilkunde und Geburtshilfe |
Laufzeit: 01.07.2015 - 30.06.2019 Gefördert durch: EU H2020 - Marie Skłodowska-Curie Actions - Research and Innovation Staff Exchange Art des Projekts: EU-Projekt koordiniert an der Universität Münster | |
Laufzeit: 01.07.2013 - 31.12.2014 Gefördert durch: Bundesministerium für Forschung, Technologie und Raumfahrt Art des Projekts: Beteiligung an einem bundesgeförderten Verbund |
| MicroRNA miR–142–3p inhibits breast cancer cell invasiveness and stem cell properties by targeting integrin alpha V, KLF4 and multiple cytoskeletal elements Götte, Martin; (12.06.2016) 2nd Matrix Biology Europe Conference, Athen, Griechenland Art des Vortrags: wissenschaftlicher Vortrag | |
| MicroRNA miR-142-3p regulates breast cancer cell invasiveness by synchronous targeting of integrin alpha V and multiple cytoskeletal elements Götte, Martin (16.11.2014) 2nd Workshop ‘Novel insights into Cancer Biology: New Targets and Therapeutic Approaches’, Kairo, Ägypten Art des Vortrags: wissenschaftlicher Vortrag | |
| MicroRNA miR-142-3p inhibits breast cancer cell invasiveness: characterization of altered morphology and functional properties Götte, Martin (09.11.2014) 18th International Microscopy Congress, Prag, Tschechien Art des Vortrags: wissenschaftlicher Vortrag |
| miR-142-3p, ein neuer Regulator der Invasivität und Motilität von MDA-MB-468-Mammakarzinomzellen Promovend*in: Schwickert, Alexander | Betreuer*innen: Götte, Martin; Greve, Burkhard Zeitraum: bis 01.07.2015 Promotionsverfahren erfolgt(e) an: Promotionsverfahren an der Universität Münster |